These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Demonstration of biological activity of brain gastrin-like peptidic material in the human: its relationship with the COOH-terminal octapeptide of cholecystokinin. Robberecht P; Deschodt-Lanckman M; Vanderhaeghen JJ Proc Natl Acad Sci U S A; 1978 Jan; 75(1):524-8. PubMed ID: 272670 [TBL] [Abstract][Full Text] [Related]
31. The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini. Gardner JD; Walker MD; Martinez J; Priestly GP; Natarajan S; Bodanszky M Biochim Biophys Acta; 1980 Jul; 630(3):323-9. PubMed ID: 6156709 [TBL] [Abstract][Full Text] [Related]
33. Degradation of cholecystokinin-like peptides by a crude rat brain synaptosomal fraction: a study by high pressure liquid chromatography. Deschodt-Lanckman M; Bui ND; Noyer M; Christophe J Regul Pept; 1981 Apr; 2(1):15-30. PubMed ID: 6262880 [TBL] [Abstract][Full Text] [Related]
34. Action of cholera toxin on dispersed acini from guinea pig pancreas. Gardner JD; Rottman AJ Biochim Biophys Acta; 1979 Jun; 585(2):250-65. PubMed ID: 222350 [TBL] [Abstract][Full Text] [Related]
35. Evidence against cyclic GMP as a mediator of the actions of secretagogues on amylase release from guinea-pig pancreas. Gardner JD; Rottman AJ Biochim Biophys Acta; 1980 Feb; 627(3):230-43. PubMed ID: 6153277 [TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of a probe for the cholecystokinin octapeptide receptor, N alpha (125I-desaminotyrosyl)CCK-8, and its interactions with pancreatic acini. Miller LJ; Rosenzweig SA; Jamieson JD J Biol Chem; 1981 Dec; 256(23):12417-23. PubMed ID: 6271785 [No Abstract] [Full Text] [Related]
37. Relationship of CCK/gastrin receptor binding to amylase release in dog pancreatic acini. Fourmy D; Zahidi A; Pradayrol L; Vayssette J; Ribet A Regul Pept; 1984 Dec; 10(1):57-68. PubMed ID: 6085178 [No Abstract] [Full Text] [Related]
38. Reversal of cholecystokinin-induced persistent stimulation of pancreatic enzyme secretion by dibutyryl cyclic GMP. Collins SM; Abdelmoumene S; Jensen RT; Gardner JD Am J Physiol; 1981 Jun; 240(6):G466-71. PubMed ID: 6166201 [TBL] [Abstract][Full Text] [Related]
39. The importance of the amino acid in position 32 of cholecystokinin in determining its interaction with cholecystokinin receptors on pancreatic acini. Pan GZ; Martinez J; Bodanszky M; Jensen RT; Gardner JD Biochim Biophys Acta; 1981 Dec; 678(3):352-7. PubMed ID: 6172156 [TBL] [Abstract][Full Text] [Related]
40. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors. Lin CW; Shiosaki K; Miller TR; Witte DG; Bianchi BR; Wolfram CA; Kopecka H; Craig R; Wagenaar F; Nadzan AM Mol Pharmacol; 1991 Mar; 39(3):346-51. PubMed ID: 1706470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]